Neutropenia Therapy
Researchers from Istanbul University, Institute of Oncology describe findings in neutropenia therapy
Published in Women's Health Weekly, January 29th, 2009
Data detailed in 'Chemotherapy with pegylated liposomal doxorubicin and cisplatin in recurrent platinum-sensitive epithelial ovarian cancer' have been presented. "Pegylated liposomal doxorubicin (PLD) is the only nonplatinum agent to significantly improve survival in patients with platinum-sensitive recurrent ovarian cancer. The present study was designed to assess the efficacy and safety of PLD plus cisplatin combination therapy in these patients," investigators in Capa, Turkey report.
"Twenty-two women (median age, 57 years) with ovarian cancer that recurred 6 months or more after standard carboplatin and paclitaxel therapy were eligible for enrollment. Cisplatin was...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Albert Einstein College of Medicine
High insulin levels raise risk of breast cancer in postmenopausal women - BioMed Central
Rheumatoid arthritis: Worse in women? - JAMA and Archives Journals
Treadmill exercise improves walking endurance for patients with peripheral arterial disease - Journal of the National Cancer Institute
HPV testing followed by cytology and repeat HPV testing may improve cervical cancer screening - Loyola University Health System
Moderate drinking can reduce risks of Alzheimer's dementia and cognitive decline - Loyola University Health System
Vitamin D is the 'it' nutrient of the moment - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
